Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    "Dysferlinopathy"
Show Display Options
RSS Create an RSS feed from your search for:
"Dysferlinopathy"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Deflazacort in Dysferlinopathies
Conditions: LGMD2B;   Miyoshi Myopathy;   Dysferlinopathy
Interventions: Drug: deflazacort;   Drug: placebo
2 Active, not recruiting Clinical Outcome Study for Dysferlinopathy
Conditions: Dysferlinopathy;   LGMD2B;   Miyoshi Myopathy
Intervention:
3 Recruiting rAAVrh74.MHCK7.DYSF.DV for Treatment of Dysferlinopathies
Condition: Dysferlinopathy
Intervention: Drug: rAAVrh74.MHCK7.DYSF.DV
4 Recruiting Proteasomal Inhibition for Patients With Mis-sense Mutated Dysferlin
Condition: Dysferlinopathy
Intervention: Drug: Bortezomib

Indicates status has not been verified in more than two years